Self-reported depression and anxiety among COPD patients. A case-control study
Palavras-chave:
Depression, Anxiety, Pulmonary disease, chronic obstructiveResumo
BACKGROUND: Anxiety and depression are the most prevalent mental disorders worldwide. However, the exact mechanisms linking chronic obstructive pulmonary disease (COPD) with depression and anxiety have not been identified. OBJECTIVES: To compare self-reported depression and anxiety among patients diagnosed with COPD in relation to healthy controls. DESIGN AND SETTING: Case control study at a public hospital institution in Spain. METHODS: We designed a case-control study. Patients were recruited using a consecutive sampling method from a single institution. Two groups were created: COPD and healthy controls. Data on medical history and demographic background were collected from the medical records. Self-reported depression levels were assessed using Beck’s depression inventory (BDI). Self-reported anxiety was measured using the State-trait anxiety inventory (STAI). RESULTS: Fifty-two patients with COPD and fifty healthy patients were included in this study. BDI scores were higher for COPD patients (10.23 ± 6.26) than in the control group (5.2 ± 6.56). STAI-state scores were higher for COPD patients (41.85 ± 12.55) than for controls (34.88 ± 9.25). STAI-trait scores were higher for COPD patients (41.42 ± 10.01) than for controls (34.62 ± 9.19). CONCLUSIONS: This study showed that there were higher levels of depression and anxiety among COPD patients than among healthy controls.
Downloads
Referências
Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095-128. PMID: 23245604; https://doi.org/10.1016/S0140-6736(12)61728-0. Erratum in: Lancet. 2013 Feb 23;381(9867):628. AlMazroa, Mohammad A [added]; Memish, Ziad A [added].
Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. PMID: 17132052; https://doi.org/10.1371/journal.pmed.0030442.
World Health Organization. Depression and other common mental disorders: global health estimates. Geneva: World Health Organization; 2017. Available from: https://apps.who.int/iris/handle/10665/254610?locale-attribute=pt&. Accessed in 2021 (Jul 8).
Tolentino JC, Schmidt SL. DSM-5 Criteria and Depression Severity: Implications for Clinical Practice. Front Psychiatry. 2018;9:450. PMID: 30333763; https://doi.org/10.3389/fpsyt.2018.00450.
Möller HJ, Bandelow B, Volz HP, et al. The relevance of ‘mixed anxiety and depression’ as a diagnostic category in clinical practice. Eur Arch Psychiatry Clin Neurosci. 2016;266(8):725-36. PMID: 27002521; https://doi.org/10.1007/s00406-016-0684-7.
Tyrer P. The case for cothymia: mixed anxiety and depression as a single diagnosis. Br J Psychiatry. 2001;179:191-3. PMID: 11532793; https://doi.org/10.1192/bjp.179.3.191.
Katon WJ. Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues Clin Neurosci. 2011;13(1):7-23. PMID: 21485743; https://doi.org/10.31887/DCNS.2011.13.1/wkaton.
Moussavi S, Chatterji S, Verdes E, et al. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007;370(9590):851-8. PMID: 17826170; https://doi.org/10.1016/S0140-6736(07)61415-9.
Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci. 2015;17(3):327-35. PMID: 26487813; https://doi.org/10.31887/DCNS.2015.17.3/bbandelow.
Friedrich MJ. Depression Is the Leading Cause of Disability Around the World. JAMA. 2017;317(15):1517. PMID: 28418490; https://doi.org/10.1001/jama.2017.3826.
Roca M, Del Amo AR, et al. Suicidal risk and executive functions in major depressive disorder: a study protocol. BMC Psychiatry. 2019;19(1):253. PMID: 31420027; https://doi.org/10.1186/s12888-019-2233-1.
von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495-9. PMID: 25046131; https://doi.org/10.1016/j.ijsu.2014.07.013.
Holt GR. Declaration of Helsinki - the world’s document of conscience and responsibility. South Med J. 2014;107(7):407. PMID: 25010578; https://doi.org/10.14423/SMJ.0000000000000131.
Miravitlles M, Soler-Cataluña JJ, Calle M, et al. Spanish Guidelines for Management of Chronic Obstructive Pulmonary Disease (GesEPOC) 2017. Pharmacological Treatment of Stable Phase. Arch Bronconeumol. 2017;53(6):324-35. PMID: 28477954; https://doi.org/10.1016/j.arbres.2017.03.018.
Garrow JS. Quetelet index as indicator of obesity. Lancet. 1986;1(8491):1219. PMID: 2871462; https://doi.org/10.1016/s0140-6736(86)91207-9.
Sanz J. 50 Years of the Beck Depression Inventories: Recommendations for the use of the Spanish adaptation of the BDI-II in clinical. Papeles de Psicólogo. 2013;34(3):161-8. Available from: https://psycnet.apa.org/record/2013-36829-001 Accessed in 2021 (Jul 12).
Beck A, Steer R, Brown G. Beck Depression Inventory-II. Manual. San Antonio, TX: The Psychological Corporation. 1996.
Renzi DA. State-Trait Anxiety Inventory. Measurement and Evaluation in Counseling and Development. 1985;18(2):86-9. https://doi.org/10.1080/07481756.1985.12022795.
Buela-Casal G, Guillén-Riquelme A. Short form of the Spanish adaptation of the State-Trait Anxiety Inventory. Int J Clin Health Psychol. 2017;17(3):261-8. PMID: 30487901; https://doi.org/10.1016/j.ijchp.2017.07.003.
Spielberger CD, Gorsuch RL, Lushene RE. STAI. Manual for the State-Trait Anxiety Inventory (“self-evaluation questionnaire”). Palo Alto, CA: Consulting Psychologists Press; 1970.
Guillén-Riquelme A, Buela-Casal G. Metaanálisis de comparación de grupos y metaanálisis de generalización de la fiabilidad del cuestionario State-Trait Anxiety Inventory (STAI) [Meta-analysis of group comparison and meta-analysis of reliability generalization of the State-Trait Anxiety Inventory Questionnaire (STAI)]. Rev Esp Salud Publica. 2014;88(1):101-12. PMID: 24728394; https://doi.org/10.4321/S1135-57272014000100007.
Atlantis E, Fahey P, Cochrane B, Smith S. Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis. Chest. 2013;144(3):766-77. PMID: 23429910; https://doi.org/10.1378/chest.12-1911.
Bailey PH. The dyspnea-anxiety-dyspnea cycle--COPD patients’ stories of breathlessness: “It’s scary /when you can’t breathe”. Qual Health Res. 2004;14(6):760-78. PMID: 15200799; https://doi.org/10.1177/1049732304265973.
Light RW, Merrill EJ, Despars JA, Gordon GH, Mutalipassi LR. Prevalence of depression and anxiety in patients with COPD. Relationship to functional capacity. Chest. 1985;87(1):35-8. PMID: 3965263; https://doi.org/10.1378/chest.87.1.35.
Goodwin RD, Lavoie KL, Lemeshow AR, et al. Depression, anxiety, and COPD: the unexamined role of nicotine dependence. Nicotine Tob Res. 2012;14(2):176-83. PMID: 22025539. https://doi.org/10.1093/ntr/ntr165.
Schneider C, Jick SS, Bothner U, Meier CR. COPD and the risk of depression. Chest. 2010;137(2):341-7. PMID: 19801582; https://doi.org/10.1378/chest.09-0614.
Jiménez-Cebrián AM, Becerro-de-Bengoa-Vallejo R, Losa-Iglesias ME, et al. The Impact of Depression Symptoms in Patients with Parkinson’s Disease: A Novel Case-Control Investigation. Int J Environ Res Public Health. 2021;18(5):2369. PMID: 33804349; https://doi.org/10.3390/ijerph18052369.
Kopschina Feltes P, Doorduin J, Klein HC, et al. Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy. J Psychopharmacol. 2017;31(9):1149-1165. PMID: 28653857; https://doi.org/10.1177/0269881117711708.
Yohannes AM, Alexopoulos GS. Depression and anxiety in patients with COPD. Eur Respir Rev. 2014;23(133):345-9. PMID: 25176970; https://doi.org/10.1183/09059180.00007813.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
